Fascicles split or merge every ∼560 microns within the human cervical vagus nerve

Author:

Upadhye Aniruddha R,Kolluru Chaitanya,Druschel Lindsey,Al Lababidi Luna,Ahmad Sami S,Menendez Dhariyat M,Buyukcelik Ozge N,Settell Megan LORCID,Blanz Stephan LORCID,Jenkins Michael W,Wilson David LORCID,Zhang Jing,Tatsuoka Curtis,Grill Warren MORCID,Pelot Nicole AORCID,Ludwig Kip AORCID,Gustafson Kenneth J,Shoffstall Andrew JORCID

Abstract

Abstract Objective. Vagus nerve stimulation (VNS) is Food and Drug Administration-approved for epilepsy, depression, and obesity, and stroke rehabilitation; however, the morphological anatomy of the vagus nerve targeted by stimulatation is poorly understood. Here, we used microCT to quantify the fascicular structure and neuroanatomy of human cervical vagus nerves (cVNs). Approach. We collected eight mid-cVN specimens from five fixed cadavers (three left nerves, five right nerves). Analysis focused on the ‘surgical window’: 5 cm of length, centered around the VNS implant location. Tissue was stained with osmium tetroxide, embedded in paraffin, and imaged on a microCT scanner. We visualized and quantified the merging and splitting of fascicles, and report a morphometric analysis of fascicles: count, diameter, and area. Main results. In our sample of human cVNs, a fascicle split or merge event was observed every ∼560 µm (17.8 ± 6.1 events cm−1). Mean morphological outcomes included: fascicle count (6.6 ± 2.8 fascicles; range 1–15), fascicle diameter (514 ± 142 µm; range 147–1360 µm), and total cross-sectional fascicular area (1.32 ± 0.41 mm2; range 0.58–2.27 mm). Significance. The high degree of fascicular splitting and merging, along with wide range in key fascicular morphological parameters across humans may help to explain the clinical heterogeneity in patient responses to VNS. These data will enable modeling and experimental efforts to determine the clinical effect size of such variation. These data will also enable efforts to design improved VNS electrodes.

Funder

NIH SPARC

Veterans Administration Medical Center

Publisher

IOP Publishing

Subject

Cellular and Molecular Neuroscience,Biomedical Engineering

Reference63 articles.

1. Expected budget impact and health outcomes of expanded use of vagus nerve stimulation therapy for drug-resistant epilepsy;Purser;Adv. Ther.,2018

2. Cyberonics announces 100,000th patient implant of VNS Therapy®,2012

3. FDA 2021 PMA approval P2100007 for vivistim system,2021

4. FDA 2015 PMA approval P130019 for maestro rechargeable system,2015

5. FDA 2005 PMA approval P970003 for VNS therapy system,2005

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3